No Validated Epithalon Age-Reversal Test Commercial testing before and after Epithalon exposure cannot establish rejuvenation unless the test is validated, the change exceeds normal variation and a controlled comparator is included
A systematic review of the musculoskeletal literature published on NIH/PMC concluded that BPC-157 shows promise for promoting recovery from musculoskeletal injuries across level IV and level V study evidence, covering preclinical data on fractures, tendon ruptures, ligament tears and muscle injuries
(PubMed) Zuin M, Cervellati C, Brombo G, Trentini A, Roncon L, Zuliani G
What Would Warrant Stopping and Why the Usual Framework Doesn't Apply For trial-backed peptides, this is where documented discontinuation criteria from clinical protocols would go
Delivery Mechanism
The side-effect profile observed in animal and in-vitro studies includes: Injection-site irritation